MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
Pharmaceutical Preparations
Latest Price
$6.88
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.39
P/B Ratio
4.95
Valuation metrics
adjust assumptions →Base FCF: $354M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$41.26
+500% upside
Institutional Ownership
81.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.97M | $62.0M | 6.74% | +625.5K | 2026-06-30 |
| BRAIDWELL LP | 8.70M | $54.0M | 5.88% | -1.54M | 2026-06-30 |
| 12 West Capital Management LP | 7.06M | $44.0M | 4.77% | -200.0K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 6.51M | $40.0M | 4.40% | +4.86M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.28M | $32.0M | 3.57% | -166.0K | 2026-06-30 |
| Ophir Asset Management Pty Ltd | 4.83M | $30.0M | 3.26% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 4.61M | $28.0M | 3.11% | +341.8K | 2026-06-30 |
| DEUTSCHE BANK AG\ | 4.30M | $26.0M | 2.91% | +3.45M | 2026-06-30 |
| First Eagle Investment Management, LLC | 3.67M | $22.0M | 2.48% | +1.15M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.13M | $19.0M | 2.12% | +301.7K | 2026-06-30 |